Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Advanced Malignant Mesothelioma: A Strategy for Improved Survival
Read full paper at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=50986#.VFHN_FfHRK0 Author(s) Stanislaw R. Burzynski , Tomasz J. Janicki , Gregory S. Burzynski , Sheldon Brookman Affiliation(s) Burzynski Clinic, Houston, TX, USA . ABSTRACT Advanced malignant mesothelioma (MM) is among the most aggressive and difficult-to-treat diseases. Industrialization and exposure to asbestos is the main causative factor for the dramatic increase in the incidence of MM, which carries a poor prognosis and a median survival of less than 12 months. Combination chemotherapy offers only palliative results; however, targeted therapy carries more promise for future successful treatment. This paper presents preliminar...